I asked some questions at this online presenting event:
I wasn't too concentrated, when Chris gave the answers, please bear with me, if I'm not reciting him 100% correctliy; perhaps there'll be a recording on youtube available to adjust my following recollection:
1. Which patents are pending (conerning the technologies) and where are they pending?
- First Chris refered to the/future corporate announcements.
- He said, they don't make a big deal of the patents/ they don't boast.
- Most patents are related the recycling business and eli-technology, following the vanadium. They have roughly 40-50 patents (pending and granted); perhaps even more?
- ELI patents: The patents are in all big mining jurisdictions applied.
- recycling patents: The patents are in all big industrialized countries applied.
2. What is setting you appart of your prime competitor metso/ what is your advantage over it?
- First he said metso can operate freely with their technology!? Builiding installations for spoke facilites to produce black mass ..... something like that.
- Then he said, primobius/sms can do the same/ have the same capabilites and in his view are better with recycling quotes (more effective an efficient?).
- Primobius's/sms's potential customers are also recyclers .... he mentioned also as potential customers companies like i.e. glencore and other recyclers.
- here I wasn't too attentive.
Again this is only my rough recollection and I'm not a native English speaker.
If the video is available, feel free to correct me.
Best
theBavarian
- Forums
- ASX - By Stock
- NMT
- General Neometals related news
NMT
neometals ltd
Add to My Watchlist
1.37%
!
7.2¢

General Neometals related news, page-4563
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.2¢ |
Change
-0.001(1.37%) |
Mkt cap ! $55.39M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 7.0¢ | $103.0K | 1.434M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 146786 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 3363 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 146786 | 0.071 |
6 | 312090 | 0.070 |
3 | 86155 | 0.069 |
2 | 154459 | 0.068 |
4 | 171400 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 3363 | 1 |
0.073 | 9087 | 1 |
0.078 | 96516 | 1 |
0.080 | 36036 | 3 |
0.083 | 17000 | 1 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
NMT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online